Product Description
Since last manyyears SaintroyLifescienceis leading manufacture, export andsupplier ofPertuzumab Injection from Surat, Gujarat, India. Pertuzumab Injection used in combination with trastuzumab and docetaxel for the treatment of metastatic HER2-positive breast cancer.
Tags: Pertuzumab Injection manufacturer, Pertuzumab Injection exporter, Pertuzumab Injection supplier,and Pertuzumab Injection, whogmp approved Pertuzumab Injection manufacturer and supplier, Pertuzumab Injection distributor, Pertuzumab Injection shipper, Pertuzumab Injection14 ml Pertuzumab Injection 14 mlsupplier, Pertuzumab Injection 14ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility in Gujarat, India.
Registration: Saintroy Lifescienceis interested in registrationof own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country:Saintroy LifesciencePertuzumab Injection Exportto USA, Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal,Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile, Somalia, Philippines,Myanmar, Maldives, Thailand, Singapore, Malaysia, Hong Kong, China, Zimbabwe,Togo, Burkina Faso, Niger,Guinea Bissau, Congo, Democratic of republic, IvoryCosta, Oman, Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba,Colombia, Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran,Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Key Uses in Breast Cancer TreatmentPertuzumab Injection is an important option for patients diagnosed with HER2-positive metastatic breast cancer. Its efficacy improves significantly when used in combination with other targeted therapies such as trastuzumab and docetaxel. The combination approach follows established oncology treatment protocols, contributing to better management and enhanced patient outcomes for this challenging cancer type.
Administration and Dosage GuidelinesThis injection must be administered intravenously by healthcare professionals experienced with oncology infusions. The proper dosage, frequency, and infusion rate depend on individual patient factors and clinical judgment. Each 14 ml glass vial contains 420 mg pertuzumab, and its neutral pH formulation helps maintain stability during administration. Always consult with your medical provider for personalized treatment planning.
Storage and Shelf Life ConsiderationsTo maintain potency and safety, store Pertuzumab Injection in a cool, dry place away from direct sunlight. The preparation remains stable and effective for up to 2 years from the manufacturing date when stored correctly. Always check the expiration date on the packaging before use and handle vials gently to preserve their integrity.
FAQ's of Pertuzumab Injection:
Q: How is Pertuzumab Injection administered to patients?
A: Pertuzumab Injection is administered as an intravenous infusion under the supervision of a healthcare professional, typically in a hospital or oncology clinic setting. Precise dosing and infusion rates are determined by the treating physician based on the patient's medical condition.
Q: What are the primary benefits of using Pertuzumab Injection for breast cancer?
A: The injection is particularly effective in treating HER2-positive metastatic breast cancer, especially when combined with trastuzumab and docetaxel. This combination therapy enhances response rates and improves overall treatment outcomes for eligible adult female patients.
Q: When should Pertuzumab Injection not be used?
A: The injection is contraindicated in patients with known hypersensitivity to pertuzumab or any excipients in the formulation. It is important to review patient history thoroughly before initiating treatment to prevent adverse reactions.
Q: Where should Pertuzumab Injection be stored for optimum effectiveness?
A: Store the vials in a cool, dry place, protected from direct light, and always keep them within the recommended storage temperature range. Proper storage ensures the stability and efficacy of the medication throughout its 2-year shelf life.
Q: What is the process of preparing Pertuzumab Injection for administration?
A: Prior to administration, the vial should be inspected to ensure the solution is clear to slightly opaque and free of particulates. The injection should always be prepared by trained personnel following aseptic techniques, and should only be infused intravenously.
Q: Can Pertuzumab Injection be given alongside other treatments?
A: Yes, Pertuzumab Injection is compatible with trastuzumab and docetaxel, and is commonly administered in combination with these agents for enhanced therapeutic benefit in HER2-positive breast cancer cases.